News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ONI BioPharma (ONI) Licenses Unique Gene Targets for Colorectal Cancer



9/30/2008 9:16:37 AM

ALACHUA, FL--(Marketwire - September 29, 2008) - ONI BioPharma Inc. (AMEX: ONI) announced today that it has entered a Collaboration Agreement with a major international diagnostics company regarding ONI's unique biomarkers for early, middle and late stage colorectal cancer. Terms of the agreement have not been disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES